// App-Quantinova.ai

BSH2020‐EP‐006 : Platelet recovery after the first cycle of DA chemotherapy for AML is an independent predictor of survival

Researchers

Presenter

  • S. Sookramanien

Principal Investigators

  • R. Szydlo

  • R. Palanicawandar

  • E. Olavarria

  • J. Apperley

  • J. Pavlu

  • A. Innes

Medical Centers

  • Centre for Haematology, Imperial College London, London,

  • Department of Neurosurgery, Imperial College Healthcare NHS Trust, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Thrombocytopenia

  • Myelodysplastic Syndrome

  • Neutropenia

Biomarkers

  • C reactive protein

  • Platelet count

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A